NMTC Earnings Date & History
NeuroOne Medical Technologies Corp (NASDAQ NMS - GLOBAL MARKET) earnings schedule, consensus estimates and reported results for the last eight quarters.
Last updated Aug 19, 2026 at 7:18 PM ET
NeuroOne Medical Technologies Corp
Health Care
- Next earnings date
- Tuesday, December 15, 2026
- Reporting session
- After Close
- EPS estimate
- $-0.19
- Revenue estimate
- $3.1M
NMTC earnings history
| Report date | Quarter | EPS est. | EPS actual | Surprise | Revenue |
|---|---|---|---|---|---|
| Thursday, August 13, 2026 | Q3 2026 | $-0.22 | $-0.28 | -26.7% | $2.0M |
| Tuesday, May 12, 2026 | Q2 2026 | $-0.23 | $-0.25 | -8.1% | $2.4M |
| Tuesday, February 17, 2026 | Q1 2026 | $-0.24 | $-0.18 | +26.5% | $2.9M |
| Wednesday, December 17, 2025 | Q4 2025 | $-0.24 | $-0.24 | +2.0% | $2.7M |
| Thursday, August 14, 2025 | Q3 2025 | $-0.31 | $-0.18 | +41.2% | $1.7M |
What the market is watching in NMTC's next report
- The full Earnings Read for this company: focus areas, peer read-through and prior-reaction context.
- Ticker Read combines trend, relative strength and catalysts in one research view.
- Scanners, Impact Radar and the members-only Weekly Watchlist are included.
Get the week's earnings by email
One free email each week: the reports that matter, when they land, and what the market is watching.
Frequently asked questions
- When is the next NMTC earnings date?
- NeuroOne Medical Technologies Corp is scheduled to report on Tuesday, December 15, 2026 (After Close). Dates can change until the company confirms them.
- Does NMTC report before or after the market?
- The next report is scheduled after close.
- What EPS is expected for NMTC?
- Consensus EPS for the upcoming quarter is $-0.19, on revenue of $3.1M.
Calendar data is provided for educational and research purposes only and is not investment advice. Release dates, times, estimates and results can change; always verify against the issuing company or agency.
NMTC earnings discussion
Anyone can read. Any free Hyper Stocks account can join in.
Create a free account to join the discussion. Reading is open to everyone — commenting is free, no subscription needed.
Loading discussion…
Member comments are opinions from individual users, not Hyper Stocks research, and are never personalised investment advice.